Evidence Review

Mastic Gum + BPC-157: What the Evidence Actually Shows

📄 11 PubMed citations

A viral protocol pairs antibacterial mastic gum with oral BPC-157 to fix H. pylori, leaky gut, and brain fog. Here is what human data supports — and where the claims outrun the science.

🔬 Unlike most 'gut-repair stack' posts, this page separates in-vitro promise from human results — and flags that BPC-157's gut-healing evidence is entirely preclinical.
🧪 Buy BPC-157 (arginine salt) at Swiss Chems →
Code HIGHPEP10 — 10% off regular-priced items
0
Completed human trials of oral BPC-157 for gut repair
2
Small human studies of mastic gum against H. pylori
25+
Years of BPC-157 gut studies — all in animals

What's in the Stack

🦠
Mastic gum vs H. pylori

Chios mastic gum (Pistacia lentiscus) damages and kills H. pylori in vitro at low concentrations (Huwez, NEJM 1998; Marone 2001). But a small human study found no reduction in H. pylori load in vivo (Bebb 2003), while a mouse study found a total mastic extract — the crude resin with its insoluble polymer removed to improve solubility — reduced H. pylori colonization ~30-fold, with the acidic triterpenic-acid fraction being the most active in vitro (Paraschos 2007).

🧬
BPC-157 & the gut lining

BPC-157 is a synthetic peptide derived from a gastric protein. In rats and mice it accelerates healing of intestinal fistulas, anastomoses, and IBD-like injury (Sikiric reviews, 2008–2011). No completed human trial has confirmed these effects; an early IBD program (PL 14736) never reached approval.

🧠
The gut-brain "brain fog" claim

H. pylori and gut inflammation are linked to the brain-gut axis (Budzyński 2014), and BPC-157 has been proposed to modulate that axis in animals (Sikiric 2023). But no human study shows this stack reverses "brain fog" — that link remains hypothesis, not result.

💊
The oral-delivery problem

Most BPC-157 gut data uses injected or gavage dosing in animals. A 2026 review flags oral BPC-157's bioavailability, stability, and regulatory hurdles as unresolved (Pharmaceutics 2026) — so "oral BPC-157" capsules are not a validated delivery route.

What the Data Shows

Mastic gum kills H. pylori (in vitro)
NEJM 1998; J Chemother 2001
Strong
Mastic gum lowers H. pylori in humans
Bebb 2003 (no effect) vs pilot 2010
Mixed
BPC-157 heals gut in animals
Sikiric et al, rat/mouse models
Strong (preclinical)
BPC-157 heals gut in humans
0 completed RCTs
None
Oral BPC-157 bioavailability validated
Unresolved (Pharmaceutics 2026)
Unproven
Stack reverses "brain fog"
No human data
Hypothesis

Key Takeaways

✅ What We Know
  • Chios mastic gum kills H. pylori in a test tube at low doses.
  • A small human study found mastic gum did NOT lower H. pylori load in vivo — it is not a proven eradication therapy and does not replace antibiotic triple/quadruple therapy.
  • BPC-157 speeds gut, fistula, and anastomosis healing across many rat and mouse studies.
  • The gut-brain axis is real: H. pylori infection is biologically linked to systemic and possibly neurological effects.
  • BPC-157 is not an FDA-approved drug; it is sold as a research chemical (Swiss Chems lists it).
⚠️ What We Don't Know
  • Whether oral BPC-157 is absorbed intact and reaches the gut wall at active doses in humans — this is unresolved.
  • Whether BPC-157 heals the human gut at all — there are zero completed human RCTs; early IBD trials never finished.
  • Whether mastic gum + BPC-157 together beat either alone, or standard care, for H. pylori or "leaky gut."
  • Whether this stack reverses "brain fog" — that claim is extrapolated from mechanism studies, not shown in people.
  • Long-term safety of oral BPC-157 in humans — no controlled safety data exists.

Frequently Asked Questions

Does mastic gum cure H. pylori?

No. Mastic gum kills H. pylori in the lab, but a small human study found it did not reduce H. pylori load in the body. It is not a substitute for the antibiotic-based triple or quadruple therapy doctors use to eradicate the infection.

Is there human evidence that BPC-157 heals the gut?

No completed human randomized trials have confirmed BPC-157 heals the gut. The gut-healing evidence comes from rat and mouse studies. An early clinical program for inflammatory bowel disease (PL 14736) never reached approval.

Does oral BPC-157 actually work, or does it need injection?

Most positive BPC-157 gut data used injection or oral gavage in animals. A 2026 review flags oral BPC-157's bioavailability and stability as unresolved, so capsule dosing in humans is not validated.

Can the mastic gum + BPC-157 stack fix brain fog?

There is no human study showing this stack reverses brain fog. The idea comes from gut-brain-axis research linking H. pylori and gut inflammation to the brain — a plausible mechanism, but not proof the stack helps cognition.

Is this stack safe?

Mastic gum is a traditional food with a long safety record at culinary and supplement doses. Oral BPC-157 has no controlled human safety data. Talk to a clinician, especially with an active H. pylori infection, which has proven treatments.

🧪 Buy BPC-157 (arginine salt) — Research Grade

Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the BPC-157 (arginine salt) product page.

Buy BPC-157 (arginine salt) at Swiss Chems →
Code HIGHPEP10 — 10% off regular-priced items

Affiliate links — support HighPeptides at no extra cost.

Peer-Reviewed References

Source 1
Mastic gum kills Helicobacter pylori
N Engl J Med · 1998
PMID: 9874617
Source 2
Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori
J Chemother · 2001
PMID: 11806621
Source 3
Mastic gum has no effect on Helicobacter pylori load in vivo
J Antimicrob Chemother · 2003
PMID: 12888582
Source 4
In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori
Antimicrob Agents Chemother · 2007
PMID: 17116667
Source 5
The effect of mastic gum on Helicobacter pylori: a randomized pilot study
Phytomedicine · 2010
PMID: 19879118
Source 6
Pentadecapeptide BPC 157 is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide system
J Pharmacol Sci · 2008
PMID: 18818478
Source 7
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Curr Pharm Des · 2011
PMID: 21548867
Source 8
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL 14736, Pliva)
Inflammopharmacology · 2006
PMID: 17186181
Source 9
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function
Pharmaceuticals (Basel) · 2023
PMID: 37242459
Source 10
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics · 2026
PMID: 42198317
Source 11
Brain-gut axis in the pathogenesis of Helicobacter pylori infection
World J Gastroenterol · 2014
PMID: 24833851
⚠️ Disclaimer

Educational purposes only. Not medical advice.

BPC-157 is not an FDA-approved drug and is sold for research use only.

H. pylori is a treatable infection with proven antibiotic regimens — consult a clinician for diagnosis and eradication; do not self-treat with supplements alone.